Canaud Ludovic, Hireche Kheira, Joyeux Frédéric, Marty-Ané Charles, Alric Pierre
Department of Vascular and Thoracic Surgery, Arnaud de Villeneuve Hospital, 191 av Doyen Gaston Giraud, Montpellier, France.
Ann Vasc Surg. 2011 Apr;25(3):327-32. doi: 10.1016/j.avsg.2010.07.024. Epub 2010 Oct 6.
The aim of this study was to evaluate the short-term and midterm results of endovascular repair of false aneurysm formation after coarctation repair.
Between November 1998 and August 2009, seven patients underwent endovascular repair for false aneurysm formation after coarctation repair (two women, five men; mean age: 45.4 ± 12.1 years; range: 30-60 years). Follow-up computed tomography scans were performed at 1 week, 3 months, 6 months, and annually thereafter.
All endografts were successfully deployed (Excluder-TAG in three patients, Talent in one patient, Valiant in three patients). Among them, six patients underwent hybrid technique with supra-aortic debranching and simultaneous or staged endovascular stent grafting as follows: transposition of the left common carotid artery (LCCA) into the brachiocephalic trunk which was later followed by transposition of the left subclavian artery into the LCCA in one case and transposition of the left subclavian artery into the LCCA in remaining five cases. No major complications occurred. A mean follow-up of 44.8 ± 41.3 months (range: 1-131 months) demonstrated no endoleak, rupture, conversion, or migration.
Short-and mid-term results of endovascular treatment of false aneurysm formation after coarctation repair favor the proposition of endovascular repair as a first-line treatment option. Long-term survival studies are mandatory to determine the efficacy and durability of this technique.
本研究的目的是评估缩窄修复术后假性动脉瘤形成的血管内修复的短期和中期结果。
1998年11月至2009年8月期间,7例患者接受了缩窄修复术后假性动脉瘤形成的血管内修复(2例女性,5例男性;平均年龄:45.4±12.1岁;范围:30 - 60岁)。术后1周、3个月、6个月及此后每年进行随访计算机断层扫描。
所有血管内移植物均成功植入(3例患者使用Excluder - TAG,1例患者使用Talent,3例患者使用Valiant)。其中,6例患者采用了主动脉弓上分支杂交技术并同时或分期进行血管内支架植入,具体如下:1例患者将左颈总动脉(LCCA)转位至头臂干,随后将左锁骨下动脉转位至LCCA;其余5例患者将左锁骨下动脉转位至LCCA。未发生重大并发症。平均随访44.8±41.3个月(范围:1 - 131个月),未发现内漏、破裂、转换或移位。
缩窄修复术后假性动脉瘤形成的血管内治疗的短期和中期结果支持将血管内修复作为一线治疗选择。必须进行长期生存研究以确定该技术的疗效和耐久性。